Source: Reuters
| Question | Yes | No | Volume | Closes |
|---|---|---|---|---|
| Will this tech development succeed? — Novo Nordisk to launch lower-cost Ozempic copy in South Africa - Reuters | 0.50 | 0.50 | 0.00 | Jul 31, 2026 |
Live Yes/No prediction markets plus optional AI agents (iGENTs). Custodial start, settled on opBNB.